Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist - Wikidata - awgldk - TriplyDB

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

http://www.wikidata.org/entity/Q28659160

about

Interleukin-1 and acute brain injury.The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice.Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects.Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development.Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats.A neuroligin-1-derived peptide stimulates phosphorylation of the NMDA receptor NR1 subunit and rescues MK-801-induced decrease in long-term potentiation and memory impairment.The detection of a synthetic Interleukin-1 receptor antagonist peptide in a seized product from a racing stable.

P2860

Q35056860-9D53A63F-A621-4546-B9D9-913BC4857AA2 Q36587295-85E02AD4-2786-47CF-8078-10B5801626CF Q36809420-DFBB73FD-1536-4609-A7CA-BAAE4403A120 Q37471491-C1A60285-E51A-4A80-B9B9-6252375D2B5D Q38697262-24011D7E-0A32-4E2C-84C2-B378F94B7008 Q40120636-0B4404DA-9DF3-4DCC-9994-1775970FE894 Q41370903-742009C5-A9BF-4F5B-8CCF-11356532C073 Q48134745-AE550C71-54F3-421A-8902-3A2A9C5AE5AE

P2860

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

http://www.wikidata.org/entity/Q28659160

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@ast

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@en

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@nl

type

label

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@ast

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@en

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@nl

prefLabel

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@ast

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@en

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@nl

P1433

Q28659160-D79918FA-4D6F-49A9-AF90-7FEF7FC5CC47

P1476

Q28659160-72A0F9DA-C835-4A8A-A293-39839BCCB08B

P2093

Q28659160-2EA138A0-A043-48FE-B8CA-0F95373A1C00

Q28659160-4A9B8BEB-C713-49DE-8D8E-91ABE17B8FAB

Q28659160-88EFE592-6E5A-4A5F-B905-8D91996D16AA

Q28659160-91C5F205-D397-4262-B6B4-7C2DD4D2E274

Q28659160-E0D4E876-DB37-4849-B20D-8CC5D8B1DE84

Q28659160-F7F7A671-BB54-4AA2-98CB-5CB2234568B4

Q28659160-FF2013A4-2F4B-4A8F-957D-EBAD588FB274

P2860

Q28659160-00621CE4-AB5B-4FE3-8B69-44C273856106

Q28659160-09EADBB7-B15C-4D6D-86A8-21F918B022D3

Q28659160-13ED570E-A0B7-4E1C-925C-96F9620FF92E

Q28659160-1B18CF87-3941-49D0-983E-E2AB478FEE3A

Q28659160-201C9076-80A6-42BE-A9D4-A475BA62D566

Q28659160-2363494D-6E7A-4FF9-A0D6-E8B5B0D83AFC

Q28659160-292113FA-3CB9-41FD-A3A2-FD058763EB5D

Q28659160-2AB01094-EC8E-4C9B-B068-0BE08C85F374

Q28659160-44326FE4-3F24-4480-9C28-989F96FD6C63

Q28659160-49EAD61D-23B6-47A6-A7C9-6BBD7C660133

P2888

Q28659160-0AFFF5D4-197F-43E2-8234-864A65EB1427

P304

Q28659160-65A9913F-EDCB-473F-AF50-4B55D7D438F2

P31

Q28659160-DEE99D45-2148-478C-8835-6232664106E7

P356

Q28659160-27BADB3F-916B-4A70-9B8D-FB4D9016F3C1

P407

Q28659160-AE428AE2-2247-4ED2-962B-61AD9E760754

P433

Q28659160-7A047674-8811-4291-8DF3-70CC34AD987E

P478

Q28659160-2CBC36FD-4444-4EC2-8DD3-407A6E2724E7

P50

Q28659160-01DC76E9-99FC-40E7-B208-5FCE5C648934

Q28659160-08C81652-5C37-4207-8921-C58041918A79

Q28659160-3D087B2C-9B85-4A03-A47F-D2D9B2B87FE5

Q28659160-8BF081F7-7E50-490A-8C13-6F2CFE9DD364

Q28659160-9A8A13FA-442D-4417-B48D-3F59251B569B

Q28659160-B29856E5-C5F1-44C8-9AB9-0AEA85FC1039

P577

Q28659160-12677276-EBDC-47F5-A71E-AB7DCFBE1F2B

P5875

Q28659160-EFA1A66E-1160-4AD7-A25A-B69BB27401E4

P6179

Q28659160-FAAA17E9-C76F-4529-8767-6EE4AC224C9B

P698

Q28659160-5BD7E121-FDAF-4EAD-ACA4-9383F2097D80

P921

Q28659160-716764f7-9d35-4b0d-af04-68fcfd28ee68

Q28659160-ECDBA78B-31E1-4E8E-A941-96111423DA63

P932

Q28659160-236C60AD-A4A3-4A17-82E4-D68DA1E18EE3

P356

1742-2094-11-27

P1433

Journal of Neuroinflammation

P1476

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

@en

P2093

Boris Klementiev

http://www.w3.org/2001/XMLSchema#string

Dan P Christensen

http://www.w3.org/2001/XMLSchema#string

Elisabeth Bock

http://www.w3.org/2001/XMLSchema#string

Laura K Kjær

http://www.w3.org/2001/XMLSchema#string

Mattias S Dahllöf

http://www.w3.org/2001/XMLSchema#string

Shizhong Li

http://www.w3.org/2001/XMLSchema#string

Vladimir Berezin

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

ACR/EULAR 2010 rheumatoid arthritis classification criteria

Structural insights into the assembly and activation of IL-1β with its receptors

A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist

The balance between IL-1 and IL-1Ra in disease

A new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survival

Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation

Interleukin 1 signaling occurs exclusively via the type I receptor

Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

P2888

1742-2094-11-27

P304

27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-11-27

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Peter Schledermann Walmod

Thomas Mandrup-Poulsen

Oksana Dmytriyeva

Stanislava Pankratova

Irina Korshunova

P577

2014-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260064418

http://www.w3.org/2001/XMLSchema#string

P6179

1003435490

http://www.w3.org/2001/XMLSchema#string

P698

24490798

http://www.w3.org/2001/XMLSchema#string

P921

P932

3923439

http://www.w3.org/2001/XMLSchema#string